Big Gain For Renalytix AI plc
Fri, Jun 30, 2023 at 07:58 PM
Renalytix AI plc (RNLX:NASDAQ) rocketted at $2.92, representing a gain of 43.8%. On Fri, Jun 30, 2023, RNLX:NASDAQ hit a New 2-Week High of $2.92. The stock appeared on our News Catalysts scanner on Thu, Jun 29, 2023 at 07:40 PM in the 'BIOTECH' category. From Fri, Jun 16, 2023, the stock recorded 33.33% Up Days and 20.00% Green Days
About Renalytix AI plc (RNLX:NASDAQ)
Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the most common and costly chronic medical conditions globally.
Top 10 Gainers:
- Viveve Medical, Inc. (VIVE:NASDAQ), 2900%
- Baudax Bio, Inc. (BXRX:NASDAQ), 124.91%
- VBI Vaccines Inc. (VBIV:NASDAQ), 75%
- Renalytix AI plc (RNLX:NASDAQ), 43.84%
- CymaBay Therapeutics, Inc. (CBAY:NASDAQ), 39.67%
- Rackspace Technology Inc. (RXT:NASDAQ), 38.78%
- Cyteir Therapeutics Inc. (CYT:NASDAQ), 35.42%
- Eiger BioPharmaceuticals, Inc. (EIGR:NASDAQ), 27.98%
- PainReform Ltd. (PRFX:NASDAQ), 27.06%
- Gracell Biotechnologies Inc. (GRCL:NASDAQ), 27%